Role of KEAP1/NFE2L2 mutations in the chemotherapeutic response of non-small cell lung cancer patients

PURPOSE: Activation of NFE2L2 has been linked to chemoresistance in cell line models. Recently, somatic mutations which activate NFE2L2, including mutations in NFE2L2, KEAP1, or CUL3, have been found to be associated with poor outcomes in patients with non-small cell lung cancer (NSCLC). However, th...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Cancer Res
Asıl Yazarlar: Jeong, Youngtae, Hellyer, Jessica A., Stehr, Henning, Hoang, Ngoc T., Niu, Xiaomin, Das, Millie, Padda, Sukhmani K., Ramchandran, Kavitha, Neal, Joel W., Wakelee, Heather, Diehn, Maximilian
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6942632/
https://ncbi.nlm.nih.gov/pubmed/31548347
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-1237
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller